Clinical TrialsSearch results
Number of results: 528
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Other
- Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT)
- Diabetic peripheral neuropathy
- The Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT) Study Group
- 2007-02-20
Other
- Trial in diabetic ulcer Using basic Fibroblast Growth Factor(KCB-1)
- Diabetic ulcer
- KAKEN PHARMACEUTICAL CO., LTD.
- 2007-09-21
Other
- Japanese Research of Cholesterol and Diabetes Mellitus
- Diabetics and the patients with impaired glucose tolerance
- AMED
- 2006-11-10
Other
- Japanese Diastolic Heart Failure Study
- Diastolic heart failure
- J-DHF Study group
- 2006-02-01
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- Clinical examination about immunoadsorption therapy for dilated cardiomyopathy
- dilated cardiomyopathy
- Department of Cardiology, Kitasato Institute Hospital
- 2007-03-01
Recruiting
- Study on Pharmacokinetic Dynamics in Blood and Tissues of Continuous Administration of Beta-Lactam Antimicrobial Agents
- Diseases that are eligible for standby lower gastrointestinal (ileum, colon, rectum, anus) surgery.
- Ohge Hiroki
- 2023-12-21
Not yet recruiting
- Effect of different cooking methods on softening of ingredients
- Disgust for test food samples
- Yoshimi Watanabe
- 2022-07-14
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07